Crispr Therapeutics shares owned by Captrust Financial Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Captrust Financial Advisors
from 13F filings
Historical chart of Captrust Financial Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Captrust Financial Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.5M | 32k | 46.98 |
| 2024-06-30 | $1.3M | 24k | 54.01 |
| 2024-03-31 | $1.7M | 25k | 68.16 |
| 2023-12-31 | $1.7M | 27k | 62.60 |
| 2023-09-30 | $1.2M | 26k | 45.39 |
| 2023-06-30 | $1.4M | 24k | 56.14 |
| 2023-03-31 | $1.2M | 26k | 45.23 |
| 2022-12-31 | $1.1M | 26k | 40.65 |
| 2022-09-30 | $1.7M | 26k | 65.34 |
| 2022-06-30 | $1.7M | 27k | 60.75 |
| 2022-03-31 | $1.3M | 21k | 62.76 |
| 2021-12-31 | $1.9M | 25k | 75.77 |
| 2021-09-30 | $2.0M | 18k | 111.93 |
| 2021-06-30 | $3.4M | 21k | 161.87 |
| 2021-03-31 | $2.7M | 22k | 121.86 |
| 2020-12-31 | $2.6M | 17k | 153.13 |
| 2020-09-30 | $1.5M | 18k | 83.36 |
| 2020-06-30 | $1.5M | 19k | 78.49 |
| 2020-03-31 | $713k | 19k | 38.51 |
| 2019-12-31 | $874k | 15k | 59.30 |
| 2019-09-30 | $41k | 1.0k | 41.00 |
| 2019-06-30 | $47k | 1.0k | 47.00 |
| 2019-03-31 | $36k | 1.0k | 36.00 |
| 2018-06-30 | $5.0k | 81 | 61.73 |
More positions owned by Captrust Financial Advisors
View all positions for Captrust Financial Advisors